Onfi and Drop attacks - a phase IV clinical study of FDA data

Summary:

Drop attacks is reported as a side effect among people who take Onfi (clobazam), especially for people who are male, 2-9 old, also take Valproic Acid, and have Infantile spasms.

The phase IV clinical study analyzes which people have Drop attacks when taking Onfi. It is created by eHealthMe based on reports of 7,698 people who have side effects when taking Onfi from the FDA, and is updated regularly.

What is Onfi?

Onfi has active ingredients of clobazam. It is often used in epilepsy. eHealthMe is studying from 7,809 Onfi users. Check the latest studies of Onfi.

What is Drop attacks?

Drop attacks (sudden spontaneous falls while standing or walking) is found to be associated with 146 drugs and 236 conditions by eHealthMe. Check the latest studies of Drop attacks.

On Jul, 16, 2026

7,698 people reported to have side effects when taking Onfi.
Among them, 24 people (0.31%) have Drop attacks.

Among these 24 people:

What is the gender of people who have Drop attacks when taking Onfi? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Drop attacks when taking Onfi? *

What are other drugs people take besides Onfi? *

What are other side effects people have besides Drop attacks? *

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 16 people, 66.67%
Drug Ineffective: 13 people, 54.17%
Developmental Delay: 12 people, 50.00%
Fall: 12 people, 50.00%
Head Injury: 7 people, 29.17%
Injury: 5 people, 20.83%
Petit Mal Epilepsy (absence seizure): 2 people, 8.33%
Atonic Seizures (minor type of seizure): 2 people, 8.33%
Fatigue (feeling of tiredness): 2 people, 8.33%
Abnormal Behavior: 2 people, 8.33%

What are the existing conditions these people have? *

Infantile Spasms: 11 people, 45.83%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 6 people, 25.00%
Tuberous Sclerosis (a rare genetic disease that causes benign tumours to grow in the brain and other organs): 1 person, 4.17%
Osteoporosis (bones weak and more likely to break): 1 person, 4.17%
High Blood Pressure: 1 person, 4.17%
Depression: 1 person, 4.17%
Complex Partial Seizures (epileptic seizure): 1 person, 4.17%
Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Onfi and have Drop attacks?

- Check whether Drop attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Onfi:

Onfi (7,809 reports)

Drop attacks treatments and more:

Drop attacks (789 reports)

Browse all side effects of Onfi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drop attacks:

Drop attacks (146 drugs)

Browse all the conditions that are associated with Drop attacks:

Drop attacks (236 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clobazam (the active ingredients of Onfi) and Onfi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.